Ray Dalio’s Medline Inc MDLN Stock Holding History

Ray Dalio’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$783K	Buy	+19,847	New	+$800K	﹤0.01%	872

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

Blackstone Inc New York $39B AUM 18.55% 1-Year Est. Return

H&F Corporate Investors X San Francisco, California $2.8B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Ray Dalio's MDLN Position: Q2 2026 in Review

Ray Dalio opened a new position in Medline Inc (MDLN) in Q2 2026: 19,847 shares worth $783K. The stake represents ﹤0.01% of the portfolio and ranks #872 among its holdings.

410 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

Ray Dalio held 19,847 shares of Medline Inc worth $783K as of Q2 2026.
Medline Inc was a new Ray Dalio position in Q2 2026.
Medline Inc made up ﹤0.01% of Ray Dalio's portfolio in Q2 2026, its #872 holding.
410 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.